Jump-starting T Cells In Skin Cancer
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins. How these vaccines work and why they are only effective in some patients remains unclear. Pierre Coulie and colleagues now show, in two articles in the January 17 issue of the Journal of Experimental Medicine, that these vaccines work by increasing the num...Special Imaging Study Shows Failing Hearts Are 'Energy Starved'
Using magnetic resonance spectroscopy (MRS) for the first time to examine energy production biochemistry in a beating human heart, Johns Hopkins researchers have found substantial energy deficits in failing hearts. The findings, published in the January 18 issue of the Proceedings of the National Academy of Sciences, confirm what many scientists have conjectured for years about heart fail...Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
A new technique might allow women diagnosed with cancer the opportunity to have children when chemotherapy and radiation treatments rob them of their fertility, researchers at the University of Michigan Comprehensive Cancer Center have found. Freezing eggs is one t...Nanotechnology may find disease before it starts
Nanotechnology may one day help physicians detect the very earliest stages of serious diseases like cancer, a new study suggests. In laboratory experiments on mice, scientists found that nano-sized particles injected into the animal...Brittlestar provides new model for stem cell research
Scientists at the Royal Swedish Academy of Sciences Kristineberg Marine Research Station are using the brittlestar as a new model for studying stem cells, allowing them to do experiments that avoid the ethical issues associated with human and vertebrate research. The brittlestar, Amphiura filiformis, is a close relative of the starfish and can regenerate lost arms in a matter of weeks. Sa...Silencer siRNA Starter Kit from Ambion
Description:The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure successful gene knockdown experiments....StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
Description:This complete kit contains enough separation reagents to perform separations from a total of 5 x 10 cells, and includes the StemSep red magnet and all the necessary reagents and buffers for the specific cell type to be enriched, including the StemSep red magnet....The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature
DNA pol...Pfu DNA Polymerase as a Hot Start Alternative
Stratagene Cloning Systems, Inc. This article describes the important, novel application of Stratagenes PfuDNA polymerase for minimizing PCR cold start mismatched primer-extensionreactions. These mismatched extension rea...prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
Michael Borns Janice Cline Kris Connors RondaAllen Holly Hogrefe Stratagene RT-PCR systems are powerfulsystems that permit efficient, high-fidelity amplification of RNA in twoconvenient formats. The ProSTAR Ultra HF RT-PCR...Greater Amplification Specificity with New Hot Start PCR Enzyme
Taq DNA polymerase makes hot start simple and efficient Jonathan Eads Frances Bai Ronda Allen Holly Hogrefe <p align="...Improve Amplification Specificity with Hot Start PCR Enzyme
Taq2000 features a modified version of Taq2000 with hot start capability. Using SureStart Taq, hot start is in- corporated into PCR protocols previously optimized with Taq DNA...Startling Expose – Physicians Often Have No Regular Source Of Health Car
Startling! But true! In a censure of the doctors around the world, a study conducted by researchers at the prestigious Yale and Johns Hopkins Universities has revealed that more than a third of physicians have no regular source of healthcare Dr. Cary P Gross of Yale University is New Haven, Connecticut says, ‘ these physicians without a regular source of health care are less likely than...Stress reduces your immunity- startling but true!!!!!
In a startling expose, new research into how our immunity works says stress reduces our immunity and makes us more vulnerable to diseases. For long we have agreed that stress is bad for our health but this aspect of stress decreasing our immune status is sure to cause a lot of concern. With the advent of HIV/AIDS and other immune-disorder related conditions claming many victims every...Starvation in pregnant women can cause heart disease to their children
Starvation during pregnancy can lead to increased risk of heart problems to their children in their adult life. Adverse foetal environment contribute to several aspects of cardiovascular risks in adult life, but they depend on the gestational time. People whose mothers starved during the first 13 weeks of pregnancy can have heart diseases later in their adult life, Starvation during mid...Heart disease threat starts early in life for Diabetics
Diabetes mellitus type I, is due to autoimmune destruction of the pancreatic islet cells that produce insulin. Result of this the body no longer produces insulin and and there is a raise in the blood sugar levels. Individuals with this type I Diabetes develop are at a higher risk to develop heart disease even at their teens. The team of researchers with the University of Southern Califor...GTx Announces Presentation of Ostarine and Acapodene Data at 2007 ASCO Annual Meeting
MEMPHIS, Tenn.--(BUSINESS WIRE)--May 25, 2007 - GTx, Inc., (NASDAQ:GTXI) announced today that data from the recent Phase II proof ofconcept clinical trial of Ostarine(TM) and from the ongoing PhaseIII clinical trial evaluating ACAPODENE(R) (toremifene citrate) 80mg for the treatment of multiple side effects of androgendeprivation therapy (ADT) will be presented at the upcoming 2007Annual Me...Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
BARCELONA, Spain, May 22, 2007 /PRNewswire/ -- Principalinvestigators for the COSTAR II (CObalt Chromium STent withAntiproliferative for Restenosis) trial, the pivotal study for theCoStar(R) cobalt chromium paclitaxel-eluting coronary stent,presented today the clinical trial results of the study at EuroPCR2007. The investigators confirmed that the study failed to meet itsprimary endpoint...Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
MENLO PARK, Calif., May 07, 2007 /PRNewswire-FirstCall/ --Citing issues related to potentially sub-optimal therapeutic dosingof paclitaxel, Conor Medsystems, LLC has concluded that the COSTARII (CObalt Chromium STent with Antiproliferative for Restenosis)trial, the pivotal study for the CoStar cobalt chromiumpaclitaxel-eluting coronary stent, failed to meet its primaryendpoint. The trial...